Teladoc Health (NYSE:TDOC) Hits New 1-Year Low at $12.36

Teladoc Health, Inc. (NYSE:TDOC - Get Free Report) shares reached a new 52-week low on Wednesday . The company traded as low as $12.36 and last traded at $12.38, with a volume of 954796 shares. The stock had previously closed at $12.88.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently issued reports on the company. Stifel Nicolaus dropped their price target on Teladoc Health from $21.00 to $16.00 and set a "hold" rating for the company in a research report on Friday, April 26th. Wells Fargo & Company cut their target price on Teladoc Health from $17.00 to $15.00 and set an "equal weight" rating for the company in a research note on Monday, April 29th. Citigroup reduced their price target on Teladoc Health from $21.00 to $19.00 and set a "neutral" rating on the stock in a report on Wednesday, February 21st. Piper Sandler dropped their price objective on shares of Teladoc Health from $30.00 to $25.00 and set an "overweight" rating for the company in a report on Wednesday, February 21st. Finally, Royal Bank of Canada reduced their target price on shares of Teladoc Health from $25.00 to $18.00 and set an "outperform" rating on the stock in a research note on Friday, April 26th. Twelve equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of "Hold" and an average price target of $18.73.

Teladoc Health Trading Down 5.4 %

The company has a debt-to-equity ratio of 0.67, a current ratio of 3.82 and a quick ratio of 3.74. The firm has a market cap of $2.07 billion, a PE ratio of -8.65 and a beta of 0.97. The company's 50 day moving average price is $14.32 and its 200 day moving average price is $17.43.

Teladoc Health (NYSE:TDOC - Get Free Report) last issued its quarterly earnings results on Thursday, April 25th. The health services provider reported ($0.49) EPS for the quarter, missing the consensus estimate of ($0.47) by ($0.02). The business had revenue of $646.13 million during the quarter, compared to analysts' expectations of $637.31 million. Teladoc Health had a negative net margin of 8.90% and a negative return on equity of 10.13%. The business's quarterly revenue was up 2.7% on a year-over-year basis. During the same period in the prior year, the business earned ($0.37) EPS. As a group, analysts forecast that Teladoc Health, Inc. will post -1.04 EPS for the current fiscal year.

Insider Activity

In related news, CAO Richard J. Napolitano sold 3,765 shares of the company's stock in a transaction that occurred on Monday, March 4th. The shares were sold at an average price of $14.52, for a total transaction of $54,667.80. Following the sale, the chief accounting officer now directly owns 18,077 shares in the company, valued at $262,478.04. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. In related news, EVP Andrew Turitz sold 6,190 shares of the business's stock in a transaction that occurred on Monday, March 4th. The stock was sold at an average price of $14.52, for a total transaction of $89,878.80. Following the completion of the sale, the executive vice president now owns 39,429 shares in the company, valued at $572,509.08. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CAO Richard J. Napolitano sold 3,765 shares of the stock in a transaction that occurred on Monday, March 4th. The shares were sold at an average price of $14.52, for a total transaction of $54,667.80. Following the completion of the transaction, the chief accounting officer now owns 18,077 shares in the company, valued at $262,478.04. The disclosure for this sale can be found here. In the last quarter, insiders sold 138,368 shares of company stock worth $1,989,227. 0.95% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

Several large investors have recently modified their holdings of TDOC. Parallel Advisors LLC lifted its holdings in shares of Teladoc Health by 14.6% in the 4th quarter. Parallel Advisors LLC now owns 4,038 shares of the health services provider's stock valued at $87,000 after purchasing an additional 515 shares during the last quarter. M&T Bank Corp boosted its holdings in shares of Teladoc Health by 5.5% in the fourth quarter. M&T Bank Corp now owns 11,152 shares of the health services provider's stock valued at $241,000 after acquiring an additional 584 shares during the period. Van ECK Associates Corp grew its position in shares of Teladoc Health by 20.3% during the fourth quarter. Van ECK Associates Corp now owns 3,589 shares of the health services provider's stock worth $77,000 after acquiring an additional 606 shares during the last quarter. Arizona State Retirement System increased its holdings in shares of Teladoc Health by 1.4% in the 3rd quarter. Arizona State Retirement System now owns 46,602 shares of the health services provider's stock valued at $866,000 after acquiring an additional 650 shares during the period. Finally, Victory Capital Management Inc. raised its position in Teladoc Health by 4.3% in the 3rd quarter. Victory Capital Management Inc. now owns 17,946 shares of the health services provider's stock valued at $334,000 after purchasing an additional 748 shares during the last quarter. Institutional investors and hedge funds own 76.82% of the company's stock.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.